Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,550 | 103 | 99.5% |
| Education | $28.12 | 2 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,572 | 60 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $950.56 | 9 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $565.01 | 11 | $0 (2019) |
| GlaxoSmithKline, LLC. | $174.26 | 12 | $0 (2024) |
| Lilly USA, LLC | $142.54 | 2 | $0 (2024) |
| Novo Nordisk Inc | $50.40 | 3 | $0 (2024) |
| PFIZER INC. | $32.54 | 2 | $0 (2023) |
| Amgen Inc. | $27.88 | 2 | $0 (2024) |
| Horizon Therapeutics plc | $17.20 | 1 | $0 (2023) |
| Astellas Pharma US Inc | $16.26 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,598 | 24 | AstraZeneca Pharmaceuticals LP ($1,108) |
| 2023 | $1,117 | 17 | AstraZeneca Pharmaceuticals LP ($598.08) |
| 2022 | $805.68 | 11 | AstraZeneca Pharmaceuticals LP ($524.26) |
| 2021 | $553.39 | 9 | AstraZeneca Pharmaceuticals LP ($538.36) |
| 2020 | $198.00 | 6 | AstraZeneca Pharmaceuticals LP ($181.95) |
| 2019 | $310.10 | 10 | Merck Sharp & Dohme Corporation ($216.24) |
| 2018 | $466.30 | 17 | Merck Sharp & Dohme Corporation ($261.57) |
| 2017 | $529.23 | 11 | AstraZeneca Pharmaceuticals LP ($403.85) |
All Payment Transactions
105 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $124.14 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $90.73 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $124.97 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $119.92 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: RESPIRATORY | ||||||
| 09/18/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $119.92 | General |
| Category: Respiratory | ||||||
| 08/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Diabetes | ||||||
| 07/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: RESPIRATORY | ||||||
| 06/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: RESPIRATORY | ||||||
| 05/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Respiratory | ||||||
| 05/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: RESPIRATORY | ||||||
| 05/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.96 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/01/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Respiratory | ||||||
| 04/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $83.48 | General |
| Category: Respiratory | ||||||
| 03/27/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $100.81 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $119.85 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug), BREZTRI, AIRSUPRA | Food and Beverage | In-kind items and services | $44.87 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/28/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Respiratory | ||||||
| 02/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: RESPIRATORY | ||||||
| 02/22/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Diabetes | ||||||
| 02/15/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/15/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $10.42 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/06/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Inflammation/Rare Disease | ||||||
| 01/31/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $124.95 | General |
| Category: Respiratory | ||||||
| 11/29/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $147.67 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,218 | 2,471 | $369,750 | $192,044 |
| 2022 | 14 | 804 | 1,822 | $261,617 | $126,673 |
| 2021 | 17 | 800 | 1,872 | $234,023 | $113,289 |
| 2020 | 17 | 1,174 | 2,201 | $302,233 | $117,952 |
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 183 | 588 | $133,147 | $79,797 | 59.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 189 | 620 | $104,954 | $58,565 | 55.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 51 | 66 | $24,176 | $14,817 | 61.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 110 | 110 | $19,139 | $14,473 | 75.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 60 | 60 | $19,552 | $8,004 | 40.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 35 | 35 | $9,327 | $5,914 | 63.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 41 | 41 | $10,833 | $3,720 | 34.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 131 | 183 | $10,494 | $1,537 | 14.6% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 13 | 73 | $1,594 | $1,113 | 69.8% |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | Office | 2023 | 18 | 21 | $7,807 | $1,004 | 12.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 44 | 65 | $2,652 | $721.35 | 27.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 96 | 138 | $2,096 | $470.58 | 22.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 25 | 25 | $724.25 | $466.00 | 64.3% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 72 | 109 | $2,592 | $397.00 | 15.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 32 | 38 | $2,603 | $361.76 | 13.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 18 | 23 | $678.04 | $262.68 | 38.7% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 41 | 46 | $3,118 | $260.36 | 8.4% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 15 | 16 | $1,088 | $97.76 | 9.0% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 23 | 144 | $7,840 | $54.01 | 0.7% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 21 | 70 | $5,338 | $6.82 | 0.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 176 | 595 | $100,717 | $53,174 | 52.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 110 | 344 | $77,895 | $48,322 | 62.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 56 | 56 | $18,248 | $8,753 | 48.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 19 | 29 | $10,623 | $6,602 | 62.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 46 | 46 | $12,154 | $4,676 | 38.5% |
About Dr. Gary Wright, M.D
Dr. Gary Wright, M.D is a General Practice healthcare provider based in Cape Coral, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841212750.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Wright, M.D has received a total of $5,578 in payments from pharmaceutical and medical device companies, with $1,598 received in 2024. These payments were reported across 105 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($5,550).
As a Medicare-enrolled provider, Wright has provided services to 3,996 Medicare beneficiaries, totaling 8,366 services with total Medicare billing of $549,957. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Practice Information
- Specialty General Practice
- Other Specialties Family Medicine
- Location Cape Coral, FL
- Active Since 07/24/2006
- Last Updated 06/16/2022
- Taxonomy Code 208D00000X
- Entity Type Individual
- NPI Number 1841212750
Products in Payments
- FARXIGA (Drug) $1,456
- BREZTRI (Drug) $1,319
- XARELTO (Drug) $950.56
- AIRSUPRA (Drug) $328.96
- BEVESPI AEROSPHERE (Drug) $212.16
- JANUMET (Drug) $206.32
- SYMBICORT (Drug) $147.43
- SIVEXTRO (Drug) $134.87
- MOUNJARO (Drug) $124.97
- TRELEGY ELLIPTA (Drug) $111.44
- BREZTRI AEROSPHERE (Drug) $108.16
- BELSOMRA (Drug) $87.20
- STEGLATRO (Drug) $86.66
- Ozempic (Drug) $50.40
- JANUVIA (Drug) $49.96
- BREO (Drug) $37.10
- KRYSTEXXA (Biological) $31.77
- ANORO (Drug) $25.72
- ELIQUIS (Drug) $19.16
- EMGALITY (Drug) $17.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Cape Coral
Dr. Phillip Kraver, Dmd, DMD
General Practice — Payments: $5,293
John Wilson
General Practice — Payments: $2,449
Sean Coyle, Dmd, DMD
General Practice — Payments: $1,848
Dr. Sudhanshu Desai, Dds, DDS
General Practice — Payments: $1,763
Dr. Brett Vartdal, Dmd, DMD
General Practice — Payments: $1,421
Lindsay Perkins
General Practice — Payments: $1,030